尊龙凯时人生就是搏·(中国区)官方网站
About Us
About Sino Biopharm
Board of Directors
Senior Management
R&D
R&D Team
Products
Product List
Sustainability
ESG Governance
ESG Management Practices
ESG Reports
Investors
Information Disclosure
Corporate Governance
Presentation
Investor FAQ
Notices
News
Press Releases
Contact
CN
EN
Investors
Home
>
Investors
>
Information Disclosure
Information Disclosure
Corporate Governance
Presentation
Investor FAQ
Notices
Information Disclosure
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME
2023.09.29
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME
2023.09.28
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME
2023.09.27
2023 INTERIM REPORT
2023.09.26
NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED SHAREHOLDERS
2023.09.26
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME
2023.09.26
VOLUNTARY ANNOUNCEMENT - IND APPLICATION OF INNOVATIVE MEDICINE "TRD205 (AT2R ANTAGONIST)" FILED WITH AND ACCEPTED BY FDA
2023.09.25
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME
2023.09.25
首页
上一页
20
21
22
23
24
25
...
53
尾页
下一页